-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Sagimet Biosciences Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2022 to Q3 2024.
- Sagimet Biosciences Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$16.9M, a 127% decline year-over-year.
- Sagimet Biosciences Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$45.7M.
- Sagimet Biosciences Inc. annual Operating Income (Loss) for 2023 was -$30.7M, a 1.01% increase from 2022.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)